Influence of different techniques on formulation and comparative characterization of inclusion complexes of ASA with β-cyclodextrin and inclusion complexes of ASA with PMDA cross-linked β-cyclodextrin nanosponges

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 74, Issue 1-4, 2012, Pages 447-454

  Shende, Pravin K ^a,b   Trotta, Francesco ^a   Gaud, R S ^b   Deshmukh, Kiran ^a   Cavalli, Roberta ^a   Biasizzo, Miriam ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies   (India)

Author keywords

Cyclodextrin; ASA; Inclusion complex; Nanosponges

Indexed keywords

EID: 84864489606     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-012-0140-x     Document Type: Article

References (21)

1. S Torne A Ansari R Vavia F Trotta R Cavalli 2010 Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges Drug Deliv. 17 419 442 10.3109/10717541003777233 1:CAS:528:DC%2BC3cXot1Wktro%3D
2. S Swaminathan R Cavalli F Trotta P Ferruti E Ranucci I Gerges A Manfredi D Marinotto P Vavia 2010 In vitro release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of β-cyclodextrin J. Incl. Phenom. Macrocycl. Chem 68 183 191 10.1007/s10847-010-9765-9 1:CAS:528:DC%2BC3cXhtFeltrnK
3. K Ansari P Vavia F Trotta R Cavalli 2011 Cyclodextrin-based nanosponges for delivery of resveratrol: In vitro characterisation, stability, cytotoxicity and permeation study AAPS PharmSciTech 12 1 10.1208/s12249-011-9584-3
4. R Cavalli F Trotta W Tumiatti 2006 Cyclodextrin-based nanosponges for drug delivery J. Incl. Phenom. Macrocycl. Chem. 56 209 213 10.1007/s10847-006- 9085-2 1:CAS:528:DC%2BD28XhtFSitrfK
5. S Swaminathan L Pastero L Serpe F Trotta P Vavia D Aquilano M Trotta G Zara R Cavalli 2010 Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity Eur. J. Pharm. Biopharm. 74 193 201 10.1016/j.ejpb.2009.11.003 1:CAS:528:DC%2BC3cXhs1Oisbw%3D
6. D Patel A Hesse A Ogunbona L Notarianni P Bennett 1990 Metabolism of aspirin after therapeutic and toxic doses Hum. Exp. Toxicol. 9 131 136 10.1177/096032719000900302 1:CAS:528:DyaK3cXkslSlurs%3D (Pubitemid 20196469)
7. J Vane R Bottin 2003 The mechanism of action of aspirin Thromb. Res. 110 255 258 10.1016/S0049-3848(03)00379-7 1:CAS:528:DC%2BD3sXosVyhsrg%3D (Pubitemid 37329821)
8. G El-Gendy K Terada K Yamamoto Y Nakai 1986 Molecular behavior, dissolution characteristics 'and chemical stability of aspirin in the ground mixture and in the inclusion complex with di-0-methyl-/3-cyclodextrin Int. J. Pharm. 31 25 31 10.1016/0378-5173(86)90209-7 1:CAS:528:DyaL28XlsFyksrs%3D (Pubitemid 16057410)
9. Szejtli, J.: Cyclodextrin technology, p. 280. Kluwer, Dordrecht (1988)
10. J Mannila T Jarvinen K Jarvinen P Jarho 2007 Precipitation complexation method produces cannabidiol/b-cyclodextrin inclusion complex suitable for sublingual administration of cannabidio J. Pharm. Sci. 96 312 319 10.1002/jps.20766 1:CAS:528:DC%2BD2sXhsFGmtLk%3D (Pubitemid 46363562)
11. Trotta, F.; Tumiatti, W.; Vallero, R.: Italian Patent No. MI2004 A000614
12. A Mele F Castiglione L Malpezzi F Ganazzoli G Raffaini F Trotta B Rossi A Fontana G Giunchi 2011 HR MAS NMR, powder XRD and Raman spectroscopy study of inclusion phenomena in β-CD nanosponges J. Incl. Phenom. Macrocycl. Chem. 69 403 409 10.1007/s10847-010-9772-x 1:CAS:528:DC%2BC3MXivVCgt7c%3D
13. P Shende R Gaud 2009 Formulation and comparative characterization of chitosan, gelatin, and chitosan-gelatin-Coated Liposomes of CPT-11-HCl Drug Dev. Ind. Pharm. 35 612 618 10.1080/03639040802498849 1:CAS:528:DC%2BD1MXlvVClu7Y%3D
14. http://www.ich.org/
15. Organization of Economic Co-operation Development: The OECD guidelines for testing of chemicals, 423. Acute oral toxicity test, Paris (2001)
16. Y Kulkarni S Gokhale A Veeranjaneyulu S Surana A Tatiya 2009 Effect of Persea macrantha against acute inflammation and adjuvant-induced arthritis in rats Pharm Biol. 47 304 308 10.1080/13880200902748437
17. S Das R Banerjee J Bellar 2005 Aspirin loaded albumin nanoparticles by coacervation: implications in drug delivery Trends Biomater. Artif. Organs 18 203 212
18. I Shekh V Gupta A Jain N Gupta 2011 Preparation and characterisation of B cyclodextrin aspirin inclusion complex Int. J. Pharm. Life Sci. 2 704 710 1:CAS:528:DC%2BC3MXlslGntrY%3D
19. F Nishioka I Nakanishi T Fujiwara K Tomita 1984 The crystal and molecular structure of the β-cyclodextrin inclusion complex with aspirin and salicylic acid J. Incl. Phenom. Macrocycl. Chem. 2 701 714 10.1007/BF00662238 1:CAS:528:DyaL2MXkslKisLg%3D
20. T Loftsson B Ólafsdóttir H Frioriksdóttir S Jónsdóttir 1993 Cyclodextrin complexation of NSAIDSs: physicochemical characteristics Eur. J. Pharm. Sci. 1 95 101 10.1016/0928-0987(93)90023-4 1:CAS:528:DyaK2cXhsVert7o%3D (Pubitemid 24055793)
21. E Boyd 1959 The acute oral toxicity of acetylsalicylic acid Toxicol. Appl. Pharmacol. 1 229 239 10.1016/0041-008X(59)90107-3 1:CAS:528: DyaG1MXhtFClu70%3D